GLP-1 Fight: Novo Sues Eli Lilly Over Nationwide "Deceptive Advertising" Campaign
--------------------------------------------------------------------
Source: Zero Hedge
Published: 2026-07-21 23:00 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Politics, Business, Crime & Justice, Law & Courts, Elections, Media, Crime & Justice
--------------------------------------------------------------------
Snippet:
Novo Nordisk wrote in a press release that it is suing GLP-1 rival Eli Lilly in federal court in New Jersey, alleging nationwide "deceptive advertising" for Zepbound and Mounjaro. The company claims Lilly misleads consumers by comparing Lilly's highest doses with lower doses of Novo's Wegovy and Ozempic.
--------------------------------------------------------------------